SRL
ZBIO icon

Scientech Research LLC’s Zenas BioPharma ZBIO Stock Holding History

Scientech Research LLC’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$229K Sell
9,028
-3,924
-30% -$78K 0.19% 144
2026
Q1 		$253K Buy
+12,952
New +$291K 0.21% 167

Other funds holding ZBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $242M AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Scientech Research LLC's ZBIO Position: Q2 2026 in Review

Scientech Research LLC reduced its Zenas BioPharma (ZBIO) stake by 30% in Q2 2026, selling an estimated $78K and leaving 9,028 shares worth $229K. The position accounts for 0.19% of the portfolio, ranked #144.

Scientech Research LLC first reported a position in ZBIO in Q1 2026 and has held it in 2 quarters since. The position peaked at $253K in Q1 2026. 144 funds tracked by Wall St. Rank hold ZBIO as of Q2 2026.

  • Scientech Research LLC held 9,028 shares of Zenas BioPharma worth $229K as of Q2 2026.
  • Scientech Research LLC sold 3,924 Zenas BioPharma shares in Q2 2026, an estimated $78K.
  • Zenas BioPharma made up 0.19% of Scientech Research LLC's portfolio in Q2 2026, its #144 holding.
  • Scientech Research LLC first reported a position in Zenas BioPharma in Q1 2026 and has held it in 2 quarters since.
  • Scientech Research LLC's Zenas BioPharma position peaked at $253K in Q1 2026.
  • 144 funds tracked by Wall St. Rank held Zenas BioPharma as of Q2 2026.

Based on Scientech Research LLC's 13F filing for Q2 2026, filed 14 Aug 2026.